Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Healthcare Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical... see more

Bullboard (TSXV:VM)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by postie1on Jun 15, 2024 8:17am

RE:RE:RE:RE:Funny

I have an inkling that very few agreements ever get signed during the Mars conference but that conference leads to discussions. Complicated legal agreements and commitments are not usually drawn up in ...more  
28
Discussion
Comment by WarrantOfficeron Jun 14, 2024 4:56pm

RE:RE:RE:Funny

MaRS link. MaRS Impact Health | Meet the brilliant minds on the frontlines of Canada’s healthcare revolution (marsdd.com) I have an inkling they have yet to secure financing...........
44
Discussion
Comment by biggdoggon Jun 14, 2024 1:18pm

RE:RE:Funny

Mars is where pharma companies get financed, form partnerships, and get laboratory support. With their new powerful molecule, I am sure they had many big pharma companies lining up to get on that ...more  
66
Discussion
Comment by whitenorth72on Jun 14, 2024 9:28am

RE:Funny

It's a very promising sign. I guess the MaRS presentation went well. The companies timing with milestones was perfect.
45
Discussion
Post by postie1on Jun 14, 2024 4:05am

Funny

As of 3:40 EST this morning thiis the top 2 levels on my trading platform . The over 700000 sell orders have completely disappeared. Make of that what you want.Sorry for having to post it this way.  ...more  
98
Discussion
Comment by Mbxwatcheron Jun 13, 2024 4:36pm

RE:RE:Value

Thank you very much. Great to get different opinions here, looks to me like its worth getting in a little deeper. GLTA
32
Discussion
Comment by Mbxwatcheron Jun 13, 2024 4:33pm

RE:RE:Value

thank you so much.........nice to see you over here as well
23
Discussion
Comment by postie1on Jun 13, 2024 4:07pm

RE:RE:RE:RE:Health Canada portal

For some reason the Rectal powder is not listed for sale yet. More testing?
25
Discussion
Comment by whitenorth72on Jun 13, 2024 2:58pm

RE:RE:RE:Health Canada portal

https://stockhouse.com/companies/bullboard/v.vm/voyageur-pharmaceuticals-ltd?postid=35963245
36
Discussion
Comment by whitenorth72on Jun 13, 2024 2:11pm

RE:Health Canada portal

I found it. It's missed spelled on the health Canada site. voyageur pharmaeuticals. What's that all about 
17
Discussion
Post by whitenorth72on Jun 13, 2024 12:57pm

Health Canada portal

Could someone post the SmoothX approval from health Canada. I'm unable to navigate through their system. Thank you
48
Discussion
Comment by WarrantOfficeron Jun 13, 2024 8:36am

RE:RE:RE:Brent seems pretty upbeat on this one.

By the lunker fish gods oldtrouf. A tint of optimism? 
23
Discussion
Post by Jonathon Brownon Jun 13, 2024 8:36am

Buzz on the Bullboards: TSX spotlight – Bombardier, Sonoro, PyroGenesis

Bombardier’s aviation advancements, Sonoro’s acquisition, and PyroGenesis' biofuel contributions highlight the opportunities in the Canada. read article.
Comment by WarrantOfficeron Jun 13, 2024 8:28am

RE:Value

Welcome Mbxwatcher.....Voyageur management has constantly over stated and under produced, thus one of the mean reasons IMO, we are sitting at .08 The future does hold promise of reaping ...more  
64
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


PRODUCTS PIPELINE CARBON DRUG PROJECT WHITE PAPER CASE STUDIES MANAGEMENT PRESENTATION

Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1